Abstract
Cardiovascular disease (CVD) is one of the major lifestyle associated disorders and leading causes of death worldwide. The incidence of CVD in diabetic patients has increased up to 3 folds and it became the major risk for diabetes associated morbidity and mortality. Insulin resistance and oxidative stress both play a central role in the pathogenesis and progression of diabetes. The high prevalence of CVD among diabetic patients suggests the role of insulin resistance and oxidative stress in developing cardiovascular complications. Finding molecular mechanisms which could control both insulin resistance and oxidative stress would be more efficacious in improving the cardiovascular complications. Recent literatures show that an epigenetic mechanism could control or regulate the cardiovascular complications in diabetes. Sirtuins, a group of enzymes, modulate epigenetic changes by deacetylating histone and non-histone proteins. These enzymes are distributed in different cell organelles and are found to regulate different biological processes. Recent findings showed that sirtuins modulate different important proteins related to insulin signaling pathway and oxidative stress. This review summarizes how sirtuins could affect the insulin resistance and oxidative stress pathways in cardiovascular system and thus attenuate the cardiovascular complications. Understanding the role of sirtuins in insulin resistance and oxidative stress will increase the prospects for controlling or preventing cardiovascular complications in the future.
Keywords: Sirtuins, SIRT, insulin resistance, acetylation, mitochondria, oxidative stress, cardiovascular complications, diabetes.
Current Pharmaceutical Design
Title:Insulin Resistance, Oxidative Stress and Cardiovascular Complications: Role of Sirtuins
Volume: 19 Issue: 32
Author(s): Pankaj K. Bagul and Sanjay K. Banerjee
Affiliation:
Keywords: Sirtuins, SIRT, insulin resistance, acetylation, mitochondria, oxidative stress, cardiovascular complications, diabetes.
Abstract: Cardiovascular disease (CVD) is one of the major lifestyle associated disorders and leading causes of death worldwide. The incidence of CVD in diabetic patients has increased up to 3 folds and it became the major risk for diabetes associated morbidity and mortality. Insulin resistance and oxidative stress both play a central role in the pathogenesis and progression of diabetes. The high prevalence of CVD among diabetic patients suggests the role of insulin resistance and oxidative stress in developing cardiovascular complications. Finding molecular mechanisms which could control both insulin resistance and oxidative stress would be more efficacious in improving the cardiovascular complications. Recent literatures show that an epigenetic mechanism could control or regulate the cardiovascular complications in diabetes. Sirtuins, a group of enzymes, modulate epigenetic changes by deacetylating histone and non-histone proteins. These enzymes are distributed in different cell organelles and are found to regulate different biological processes. Recent findings showed that sirtuins modulate different important proteins related to insulin signaling pathway and oxidative stress. This review summarizes how sirtuins could affect the insulin resistance and oxidative stress pathways in cardiovascular system and thus attenuate the cardiovascular complications. Understanding the role of sirtuins in insulin resistance and oxidative stress will increase the prospects for controlling or preventing cardiovascular complications in the future.
Export Options
About this article
Cite this article as:
Bagul K. Pankaj and Banerjee K. Sanjay, Insulin Resistance, Oxidative Stress and Cardiovascular Complications: Role of Sirtuins, Current Pharmaceutical Design 2013; 19 (32) . https://dx.doi.org/10.2174/13816128113199990372
DOI https://dx.doi.org/10.2174/13816128113199990372 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Linalool as a Therapeutic and Medicinal Tool in Depression Treatment: A
Review
Current Neuropharmacology Relationship Between Cigarette Smoking and Other Coronary Risk Factors in Atherosclerosis: Risk of Cardiovascular Disease and Preventive Measures
Current Pharmaceutical Design Beta-blockers in Intensive Care Medicine: Potential Benefit in Acute Brain Injury and Acute Respiratory Distress Syndrome
Recent Patents on Cardiovascular Drug Discovery Selective Serotonin Reuptake Inhibitors in Pregnancy
Current Medicinal Chemistry Therapeutic Management of COVID-19 Patients: Clinical Manifestation and Limitations
Current Pharmaceutical Design Neuropeptide Y Induces Cardiomyocyte Hypertrophy <i>via</i> Attenuating miR-29a-3p in Neonatal Rat Cardiomyocytes
Protein & Peptide Letters Editorial from Editor-in-Chief: Amniotic Pulmonary Embolism and the Respiratory System: Management Trends and Future Options
Current Respiratory Medicine Reviews Peroxisome Proliferator-Activated Receptors and the Control of Fatty Acid Oxidation in Cardiac Hypertrophy
Mini-Reviews in Medicinal Chemistry The Role of Flavonoids in Inhibiting IL-6 and Inflammatory Arthritis
Current Topics in Medicinal Chemistry The Role of Chemokines, Cytokines and Adhesion Molecules in Stem Cell Trafficking and Homing
Current Pharmaceutical Design Heart Failure in East Asia
Current Cardiology Reviews Free Fatty Acids: Circulating Contributors of Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Role of the Renin-Angiotensin-Aldosterone System in the Pathogenesis of Atherosclerosis
Current Pharmaceutical Design Molecular Imaging of Myocardial Inflammation: More Evidence Toward a Causative Role in Cardiovascular Disease
Current Radiopharmaceuticals Expression of microRNAs (133b and 138) and Correlation with Echocardiographic Parameters in Patients with Alcoholic Cardiomyopathy
MicroRNA Emerging Role for RBM20 and its Splicing Substrates in Cardiac Function and Heart Failure
Current Pharmaceutical Design Supplementation of Creatine and Ribose Prevents Apoptosis and Right Ventricle Hypertrophy in Hypoxic Hearts
Current Pharmaceutical Design Ghrelin and Cardiovascular Diseases
Current Cardiology Reviews Management of Incidental Findings in the Era of Next-generation Sequencing
Current Genomics Preface
Current Cardiology Reviews